Retraction to: Cell Death and Disease 10.1038/s41419-020-03266-3, published online 12 December 2020
The Editors-in-Chief have retracted this article at the authors’ request. After publication, concerns were raised regarding image similarities between this article and a number of previously published articles, specifically:
Several images in Fig. 6D and E appear highly similar to those in Fig. 6C and D in [1], Fig. 6D and E in [2], Fig. 5E and F in [3], and Fig. 7E in [4].
Fig. 5E input appears highly similar to Fig. 4E input in [1].
The authors have stated that the images in Fig. 6 were misused and could not be reproduced, which undermined the reliability of the conclusions. The Editors-in-Chief therefore no longer have confidence in the presented data and the conclusions of the article.
All authors agree to this retraction.
Contributor Information
Xiao Tan, Email: tanx206@163.com.
Jing-Shan Tong, Email: tongjingshan@gmail.com.
References
- 1.Lin L, Ding D, Jiang Y. MEK inhibitors induce apoptosis via FoxO3a-dependent PUMA induction in colorectal cancer cells. Oncogenesis. 2018;7:67. doi: 10.1038/s41389-018-0078-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Yue D, Sun X. Idelalisib promotes Bim-dependent apoptosis through AKT/FoxO3a in hepatocellular carcinoma. Cell Death Dis. 2018;9:935. doi: 10.1038/s41419-018-0960-8. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 3.Yan J, Yang S, Tian H. Copanlisib promotes growth inhibition and apoptosis by modulating the AKT/FoxO3a/PUMA axis in colorectal cancer. Cell Death Dis. 2020;11:943. doi: 10.1038/s41419-020-03154-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Cao Y, Li X. CDK4/6 inhibition suppresses tumour growth and enhances the effect of temozolomide in glioma cells. J Cell Mol Med. 2020;24:5135–45. doi: 10.1111/jcmm.15156. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]